SEC Form D · filed August 9, 2019
ZIOPHARM ONCOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Eleanor M. De Groot · Boston, MAExecBradford G. Jackson · Seattle, WAExecAravt Global LLC · New York, NYDirectorMurat Ozbaydar · New York, NYExecSath M. Shukla · Boston, MAExecKristy R. Trieste · NEW YORK, NYDirectorEleanor M. De Groot · Boston, MAExecEd Braswell · Brentwood, TNExec · DirectorHeidi M. Hagen · Boston, MADirectorJames D. Mitchell · Seattle, WAExecJill M. Buck · Boston, MAExecStephen J. Ketchum · New York, NYDirectorHeidi M. Hagen · Boston, MADirectorJill M. Buck · Boston, MAExecSath M. Shukla · Boston, MAExecJason K. Mendelson · Boulder, CODirectorMark R. Kessler · New York, NYExecArthur N. Budge, Jr · CAMARILLO, CAExec · DirectorUmit Alptuna · New York, NYExecAli Hamed · New York, NYDirectorRob Heyvaert · NEW YORK, NYExecYieldStreet Management LLC · New York, NYDirectorDawn Howe · Grand Cayman, Cayman IslandsDirectorBill Sasser · Brentwood, TNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗